Clik here to view.
Chi-Med Presents Pre-clinical Data for Selective Syk Inhibitor HMPL-523 at...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that data from a recent pre-clinical study, investigating the in vitro and in vivo anti-tumor activities of...
View ArticleClik here to view.
Astellas Research & Development Meeting Highlights
TOKYO Astellas Pharma Inc. (Tokyo: 4503, President and CEO: Yoshihiko Hatanaka, “the Company”) announced that it is holding a research and development (R&D) meeting for securities analysts,...
View ArticleClik here to view.
Clik here to view.
Provision Healthcare的ProNova SC360质子治疗系统获得FDA核准
田纳西州诺克斯维尔 (美国商业资讯) — Provision Healthcare的研发和制造分支ProNova Solutions的SC360质子治疗系统已获得FDA 510(k)核准，该核准距研发启动仅有4年时间。这是首台也是唯一一台能够从所有角度治疗患者而无需移动患者的紧凑型360度笔尖束扫描质子治疗系统，实现了最高效的临床工作流程，提高了治疗精度和患者舒适性。...
View ArticleClik here to view.
プロビジョン・ヘルスケアがProNova SC360陽子線治療システムのFDA承認を取得
米テネシー州ノックスビル （ビジネスワイヤ） — プロビジョン・ヘルスケアの子会社として研究・開発・製造を手掛けるプロノーバ・ソリューションズは、SC360陽子線治療システムの研究開発を開始してわずか4年で、FDAから...
View ArticleClik here to view.
Clik here to view.
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of...
NEW YORK & TOKYO Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503) today announced the Phase 4 PLATO study, evaluating the efficacy and safety of continued treatment with XTANDI®...
View ArticleClik here to view.
Baxter to Expand Portfolio of Essential Generic Injectable Medicines with...
DEERFIELD, Ill. Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today entered into a definitive agreement to acquire Claris Injectables Limited,...
View ArticleClik here to view.
Radiation Oncology Centres Launches Australia’s First Electronic...
BRISBANE, Australia Elekta (STO:EKTAB) On December 8, a female patient in her 60s became the first in the Australia / New Zealand region to receive electronic brachytherapy to treat her skin cancer...
View ArticleClik here to view.
和铂医药全资收购全球医药行业核心技术平台，打造专注肿瘤免疫领域的世界顶级生物科技公司
美国马萨诸塞州剑桥、中国上海、荷兰鹿特丹 (美国商业资讯)– 和铂医药，一家总部位于中国的新创公司，今天宣布以现金加股权的方式收购总部位于荷兰的Harbour Antibodies BV公司，并将在此基础上，打造专注肿瘤免疫领域的世界顶级生物医药公司。新公司将运用其拥有全面专利保护的Harbour...
View ArticleClik here to view.
Harbour BioMed Acquires Harbour Antibodies to Create Global, Oncology-focused...
CAMBRIDGE, Mass. & SHANGHAI & ROTTERDAM, The Netherlands Harbour BioMed, a recently established Shanghai-based company, today announced it has acquired Harbour Antibodies BV for cash and an...
View ArticleClik here to view.
ノボキュア・オプチューン（NovoTTF-100A）が 神経膠芽腫の治療用機器として厚生労働省より初発患者への適用拡大を承認
ジャージー州セント・ヘリア発 （ビジネスワイヤ） — ノボキュア社（NASDAQ:...
View ArticleClik here to view.
Exelixis and Ipsen amend exclusive licensing agreement for the...
PARIS & SOUTH SAN FRANCISCO, Calif. Regulatory News: Exelixis, Inc. (NASDAQ: EXEL) and Ipsen (Euronext: IPN; ADR: IPSEY) today jointly announced an amendment to the exclusive collaboration and...
View ArticleClik here to view.
Provectus Biopharmaceuticals Announces Two Poster Presentations on PV-10 for...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.provectusbio.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or “The Company”), today...
View ArticleClik here to view.
CORRECTING and REPLACING Provectus Biopharmaceuticals Announces Two Poster...
KNOXVILLE, Tenn. In the subhead and third paragraph of the release, the dates for the Asian Pacific Association for the Study of the Liver (APASL) Conference should read February 15-19, 2017. The...
View ArticleClik here to view.
CellMax Life Takes Liquid Biopsy to Next Level with 73 Gene Profile ctDNA...
SUNNYVALE, Calif. CellMax Life, the precision cancer testing company, announced today the commercial availability of CellMax-LBx Liquid Biopsy in India. CellMax-LBx is a cancer blood test which...
View ArticleClik here to view.
Minomic Announces Clinical Study Update for MILGa in Prostate, Bladder and...
SYDNEY Minomic International Ltd (Minomic) is an immuno-oncology company specializing in therapeutics and diagnostics for solid tumors, including prostate, bladder and pancreas. The Company today...
View ArticleClik here to view.
Biodesix® and Bioyong Announce Agreement for Joint Development and...
BOULDER, Colo. Biodesix, Inc. and Bioyong Technology Company Ltd. (Beijing, China) announced today that they have entered into an international collaboration agreement where Bioyong will develop and...
View ArticleClik here to view.
Kite Pharma Establishes a Strategic Partnership With Daiichi Sankyo to...
SANTA MONICA, Calif. Kite Pharma (Nasdaq:KITE) announced today that it has entered into a strategic partnership with Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) for axicabtagene ciloleucel (approved...
View ArticleClik here to view.
Kite Pharma and Fosun Pharma Establish Joint Venture in China to Develop and...
SANTA MONICA, Calif. & SHANGHAI Kite Pharma (Nasdaq:KITE) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) (600196.SH,02196.HK), today announced a joint venture, Fosun Pharma...
View Article